Trials / Completed
CompletedNCT04730102
Rectal Washout in Transanal Total Mesorectal Excision and Presence of Intraluminal Malignant Cells
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- Slagelse Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to assess the existence of intraluminal malignant cells and the appropriate fluid volume needed to perform rectal washout during transanal total mesorectal excision (taTME) for rectal cancer.
Detailed description
Twenty patients undergoing taTME for rectal cancer is included. Following the closure of the rectal lumen by a purse string suture, rectal washout is performed with a total of 500 ml sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline after each washout. A sixth sample is collected from the presacral cavity. Each sample is cytologically examined by a pathologist and labelled either malignant or non-malignant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Rectal washout | Rectal washout is performed intraoperatively before transection and means irrigation of the rectum following the closure of the rectal lumen below the tumour with a purse string suture. Rectal washout is performed with a total of 500 ml sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline after each washout. A sixth sample is collected from the presacral cavity. |
Timeline
- Start date
- 2020-02-13
- Primary completion
- 2021-02-09
- Completion
- 2021-02-09
- First posted
- 2021-01-29
- Last updated
- 2021-02-10
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04730102. Inclusion in this directory is not an endorsement.